ACALABRUTINIB vs ACETAMINOPHEN: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
ACALABRUTINIB vs ACETAMINOPHEN: Safety Overview
| Metric | ACALABRUTINIB | ACETAMINOPHEN |
|---|---|---|
| Total FAERS Reports | 9,688 | 136,761 |
| Deaths Reported | 2,239 | 30,085 |
| Death Rate | 23.1% | 22.0% |
| Hospitalizations | 2,441 | 50,046 |
| Average Patient Age | 73.2 yrs | 48.9 yrs |
| % Female Patients | 36.8% | 68.3% |
| FDA Approval Date | Aug 3, 2022 | Approved Prior to Jan 1, 1982 |
| Manufacturer | AstraZeneca Pharmaceuticals LP | Cranbury Pharmaceuticals, LLC |
| Route | ORAL | ORAL |
| Marketing Status | Prescription | Discontinued |